ZJYL (Jin Medical International) Net Profit

Corporate emblem and logo of Jin Medical International (ZJYL)

The balance of income and expenses demonstrates the financial stability of Jin Medical International. The assembly of rehabilitation equipment relies on the procurement of profiles and tires from external partners. Profit is generated through the sale of beds and wheelchairs to clinics and nursing homes. Global population aging ensures long-term demand growth. The value of 0.00 determines this parameter level.

ZJYL: Jin Medical International Net Profit 02/21/2024 - 11/01/2026

Financial and market metric breakdowns for zhjmedical.com (ZJYL)

- current quotes and average value forecast:
Market Chart Jin Medical|ZJYL - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization ZJYL|ZJYL - Total Company Value
- book capitalization data:
Net Assets per Single Share Jin Medical International|ZJYL - Book Capitalization|Market Capitalization to Book Value zhjmedical.com|ZJYL - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Jin Medical International|ZJYL - Long-Term Debt to Capital|Current Liabilities to Capital Jin Medical|ZJYL - Company Aggregate Debts|Debt to Book Value Ratio ZJYL|ZJYL - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Jin Medical International|Quick Liquidity Indicator zhjmedical.com
- earnings and valuation multiples information:
ZJYL - Net Profit
Fundamental valuation:Jin Medical International Ltd
Product sample of Jin Medical International

For Jin Medical International (ZJYL), a leader in the production of high-tech rehabilitation equipment, corporate profit reflects the efficiency of innovation monetization and global brand trust. This indicator captures daily financial results, neutralizing reporting time lags through cash flow analysis, which allows investors to assess current operational capital stability and detect growth stagnation in a timely manner.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit OFIX|BVS (Bioventus) - Net Profit|OrthoPediatrics Inc. (KIDS) - Net Financial Result|Net Profit TMCI|Net Income Strata Medical SRTA|Net Profit CARL (Carlsmed Inc)|Net Profit rxsight.com RXST|CLPT - Company Net Income|STXS: Company Net Income|STIM (NeuroStar) - Net Income|Sight Sciences Inc - Final Profit|OBIO (Orchestra BioMed) - Net Profit|Company Net Income Anika ANIK|Company Net Income InspireMD (NSPR)|vivani.com (VANI) - Annual Net Income|Xtant Medical - Net Income|Net Profit NeuroOne Medical Technologies Corp. NMTC|Modular Med - Net Profit|Net Financial Result myomo.com MYO|Envoy Medical (COCH) - Company Net Income|Profit After Tax VVOS (Vivos Therapeutics Inc.)|Company Net Income enVVeno|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOLASE, Inc. (BIOL) - Company Net Income|DYNT: Profit After Payment of Taxes|FNA (Paragon 28 Inc.) - Net Profit|INVO Bio (INVO) - Net Financial Result